The 1st @US_FDA approved deep learning #AI device for 1°care today: diagnosis of diabetic retinopathy w/o ophthalmologists. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357 … But no published data. Website claims 87% sensitivity, 90% specificity from 900 patient trial. + @SGottliebFDA's upbeat #AI tweets.pic.twitter.com/ScphZajXVg
By (@EricTopol) The 1st @US_FDA approved deep learning #AI device for 1°care today: diagnosis of diabetic retinopathy w/o ophthalmologists. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604357 …
But no published data. Website claims 87% sensitivity, 90% specificity from 900 patient trial.
+ @SGottliebFDA's upbeat #AI ...